ENDV vs EMYB: Which is Better to Buy in 2026?

Side-by-side fundamental comparison based on AI analysis of SEC filings

AI Verdict

EMYB has stronger fundamentals based on our AI analysis.

ENDV
ENDONOVO THERAPEUTICS, INC.
STRONG SELL
95%
Confidence
VS
EMYB
Embassy Bancorp, Inc.
HOLD
62%
Confidence

ENDV vs EMYB Fundamental Comparison

Metric ENDV EMYB
Revenue $134,260.0 $71.5M
Net Income $8.5M $13.7M
Net Margin 6,351.8% 19.2%
ROE N/A 10.7%
ROA 1,045.4% 0.8%
Current Ratio 0.00x N/A
Debt/Equity N/A 0.11x
EPS $0.00 $1.79

Green = Better metric | Red = Weaker metric

View Full ENDV Analysis →
View Full EMYB Analysis →

You Might Also Compare

ENDV vs AAPL EMYB vs MSFT ENDV vs GOOGL EMYB vs AMZN

ENDV vs EMYB: Frequently Asked Questions

Is ENDV or EMYB a better buy in 2026?

Based on dual AI fundamental analysis (Claude and ChatGPT), EMYB has stronger fundamentals. ENDV is rated STRONG SELL (95% confidence) while EMYB is rated HOLD (62% confidence). This is not investment advice.

How does ENDV compare to EMYB fundamentally?

ENDONOVO THERAPEUTICS, INC. has ROE of N/A vs Embassy Bancorp, Inc.'s 10.7%. Net margins are 6,351.8% vs 19.2% respectively.

Which stock pays higher dividends, ENDV or EMYB?

ENDV has a dividend yield of N/A or no dividend while EMYB has N/A or no dividend. Check individual stock pages for detailed dividend history and payout ratios.

Should I invest in ENDV or EMYB for long term?

For long-term investing, consider that ENDV has STRONG SELL rating with 95% confidence, while EMYB has HOLD rating with 62% confidence. Higher confidence indicates more consistent fundamentals from SEC filings. This is not investment advice - always do your own research.

What do the AI models say about ENDV vs EMYB?

Our dual AI system (Claude by Anthropic and ChatGPT by OpenAI) analyzes SEC 10-K and 10-Q filings independently. For ENDV vs EMYB, the AI consensus favors EMYB based on fundamental metrics including revenue growth, profitability, ROE, and balance sheet strength.